205 related articles for article (PubMed ID: 25882524)
1. New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation.
Danac R; Al Matarneh CM; Shova S; Daniloaia T; Balan M; Mangalagiu II
Bioorg Med Chem; 2015 May; 23(10):2318-27. PubMed ID: 25882524
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure, antimycobacterial and anticancer evaluation of new pyrrolo-phenanthroline derivatives.
Al Matarneh CM; Mangalagiu II; Shova S; Danac R
J Enzyme Inhib Med Chem; 2016; 31(3):470-80. PubMed ID: 25945747
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2007 Mar; 340(3):147-53. PubMed ID: 17315260
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII
Olaru AM; Vasilache V; Danac R; Mangalagiu II
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1291-1298. PubMed ID: 29072097
[TBL] [Abstract][Full Text] [Related]
5. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.
Mantu D; Antoci V; Moldoveanu C; Zbancioc G; Mangalagiu II
J Enzyme Inhib Med Chem; 2016; 31(sup2):96-103. PubMed ID: 27250919
[TBL] [Abstract][Full Text] [Related]
6. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds.
Ghinet A; Abuhaie CM; Gautret P; Rigo B; Dubois J; Farce A; Belei D; Bîcu E
Eur J Med Chem; 2015 Jan; 89():115-27. PubMed ID: 25462232
[TBL] [Abstract][Full Text] [Related]
7. A facile stereoselective synthesis of dispiro-indeno pyrrolidine/pyrrolothiazole-thiochroman hybrids and evaluation of their antimycobacterial, anticancer and AchE inhibitory activities.
Bharkavi C; Vivek Kumar S; Ashraf Ali M; Osman H; Muthusubramanian S; Perumal S
Bioorg Med Chem; 2016 Nov; 24(22):5873-5883. PubMed ID: 27687968
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
Shen YM; Lv PC; Chen W; Liu PG; Zhang MZ; Zhu HL
Eur J Med Chem; 2010 Jul; 45(7):3184-90. PubMed ID: 20304535
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
Ikeda T; Yaegashi T; Matsuzaki T; Yamazaki R; Hashimoto S; Sawada S
Bioorg Med Chem Lett; 2011 Oct; 21(19):5978-81. PubMed ID: 21865039
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro anticancer and antimycobacterial evaluation of new 5-(2,5-dimethoxyphenyl)-1,3,4-thiadiazole-2-amino derivatives.
Polkam N; Rayam P; Anireddy JS; Yennam S; Anantaraju HS; Dharmarajan S; Perumal Y; Kotapalli SS; Ummanni R; Balasubramanian S
Bioorg Med Chem Lett; 2015 Apr; 25(7):1398-402. PubMed ID: 25765907
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial activity of 1-substituted indolizines.
Gundersen LL; Negussie AH; Rise F; ØStby OB
Arch Pharm (Weinheim); 2003 Jun; 336(3):191-5. PubMed ID: 12822185
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N,N-disubstituted dithiocarbamate/O-alkyldithiocarbonate derivatives.
Güzel O; Salman A
Bioorg Med Chem; 2006 Dec; 14(23):7804-15. PubMed ID: 16931027
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53.
Moon SH; Jung Y; Kim SH; Kim I
Bioorg Med Chem Lett; 2016 Jan; 26(1):110-3. PubMed ID: 26608553
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Molecular Modelling and Anticancer Activities of New Fused Phenanthrolines.
Al Matarneh CM; Amarandi RM; Craciun AM; Mangalagiu II; Zbancioc G; Danac R
Molecules; 2020 Jan; 25(3):. PubMed ID: 31991806
[TBL] [Abstract][Full Text] [Related]
15. Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs.
Roy S; Hagen KD; Maheswari PU; Lutz M; Spek AL; Reedijk J; van Wezel GP
ChemMedChem; 2008 Sep; 3(9):1427-34. PubMed ID: 18537202
[TBL] [Abstract][Full Text] [Related]
16. Self-assembly of novel molecular complexes of 1,10-phenanthroline and 5-amino-1,10-phenanthroline and evaluation of their in vitro antitumour activity.
Kaloyanov N; Alexandrova R; Wesselinova DW; Mayer-Figge H; Sheldrick WS; Dimitrov GD
Eur J Med Chem; 2011 Jun; 46(6):1992-6. PubMed ID: 21474217
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis.
Gundersen LL; Charnock C; Negussie AH; Rise F; Teklu S
Eur J Pharm Sci; 2007 Jan; 30(1):26-35. PubMed ID: 17079120
[TBL] [Abstract][Full Text] [Related]
18. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events.
Lucescu L; Ghinet A; Belei D; Rigo B; Dubois J; Bîcu E
Bioorg Med Chem Lett; 2015 Sep; 25(18):3975-9. PubMed ID: 26227778
[TBL] [Abstract][Full Text] [Related]
19. New water-soluble copper (II) complexes including 4,7-dimethyl-1,10-phenanthroline and L-tyrosine: synthesis, characterization, DNA interactions and cytotoxicities.
İnci D; Aydın R; Yılmaz D; Gençkal HM; Vatan Ö; Çinkılıç N; Zorlu Y
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt B():761-70. PubMed ID: 25448975
[TBL] [Abstract][Full Text] [Related]
20. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
Ruiz J; Vicente C; de Haro C; Bautista D
Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
